BRNS · Barinthus Biotherapeutics plc

NASDAQ Global MarketHealthcareBiotechnology

Barinthus Biotherapeutics Plc Is A Clinical-Stage Biopharmaceutical Company Focused On Developing Novel Immunotherapeutic Drug Candidates For Treating Autoimmune And Inflammatory Diseases. The Company Is Prioritizing The Development Of Its Proprietary Snap-Ti Platform, Designed To Promote Immune Tolerance, With Its Lead Candidate Vtp-1000 Targeting Celiac Disease. It Is Also Developing Vtp-300 For Chronic Hepatitis B Using Viral Vector Platform Technologies, Aimed At Inducing Disease-Specific Immune Responses.

HealthcareNASDAQ Global MarketUSMid Float

FLOAT

39.4M

FREE FLOAT %

97%

SHARES O/S

40.8M

MARKET CAP

$30.2M

EXCHANGE

NASDAQ Global Market

COUNTRY

BRNS Catalyst History

No catalysts recorded for BRNS yet

Day Trader Sniper hasn't classified a publishable catalyst for BRNS yet. New events appear here as they're scored.

Be early on the next BRNS spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

BRNS · Barinthus Biotherapeutics plc

BRNS Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.